OS
OS Therapies Incorporated
OSTX · AMEX
$1.69 -7.42% (-$0.14)
1M +14.29%
Market Cap $76.7M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$2.47
46.6% upside
Trenutna cena
$1.69
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica OSTX trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
1/9Valuation
-
N/A EV/EBITDA N/A
P/S N/A
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
58 /100
Average ROA 0.63%
Asset turnover 0.00x
ROIC 346.84%
Debt
43 /100
Moderate Int. coverage -484.86x
Current ratio 176.37x
Net debt/EBITDA N/A
Stability
47 /100
Moderate EPS volatility 30.26%
Profitable years 0
Beta -0.68x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o OSTX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Paul A. Romness
Employees
5
Headquarters
Grasonville
Prihajajoči dogodki
13 NOV.
Earnings
Upcoming earnings report